Acute Neurologic Deterioration & Brain Death Workflow
From acute GCS drop and herniation emergency measures to emergent CT, neurocritical intervention, and death by neurologic criteria determination.
An educational representation of clinical reasoning, not a diagnostic algorithm or personalized medical advice — always apply clinical judgment and institutional protocols.
Caution
Escalate — Red Flags & Critical Warnings
- Even a single episode of hypotension (SBP < 90 mmHg or MAP < 65) or hypoxemia (SpO2 < 90%) in acute brain injury doubles patient mortality — aggressively defend cerebral perfusion pressure (CPP = MAP - ICP >= 60–70 mmHg).
- BD/DNC determination must NOT proceed until CNS-depressant drug effects are excluded. Use measured drug levels when available or allow at least 5 drug half-lives, extending this interval for renal/hepatic dysfunction, obesity, hypothermia, prolonged infusions, or active metabolites. EEG does not demonstrate sedative clearance and is not an accepted ancillary test for BD/DNC under the 2023 consensus guideline.
Related Bedside Clinical Problems (16)
Bedside PresentationsTriaging rising PaCO2: distinguishing acute uncompensated acidemia from chronic compensation, identifying central vs pump vs dead-space failure, and titrating noninvasive ventilation.
Acute bradyarrhythmia management: identifying hemodynamic instability, distinguishing sinus node arrest vs high-grade AV block, medical chronotropic support (atropine, epinephrine), and emergent pacing.
Differentiating hypertensive emergency (acute target organ damage) from asymptomatic hypertension: tailored pressure targets for SCAPE, aortic dissection, hemorrhagic stroke, and ischemic stroke.
Linked Deep-Dive Topics (8)
Reference KnowledgeARAS neuroanatomy, structural vs toxic-metabolic coma, the comprehensive Coma Exam (pupils, cold calorics, posturing), FOUR score, and CAM-ICU delirium.
Core vs penumbra dynamics, ASPECTS & CT perfusion, Tenecteplase/Alteplase thrombolysis, DAWN/DEFUSE 3 extended thrombectomy, BP targets, and malignant MCA hemicraniectomy.
Spontaneous ICH vs Aneurysmal SAH, INTERACT-2/ATACH-2 blood pressure targets, emergency anticoagulant reversal, ENRICH minimally invasive evacuation, ISAT coiling, and Nimodipine for delayed cerebral ischemia.
Monro-Kellie doctrine, ICP waveforms (P2>P1, Lundberg A-waves), CPP targets (60–70 mmHg), herniation syndromes, and the 4-tier BTF management protocol.
Severe TBI neurocritical care: prevent hypoxemia/hypotension, treat intracranial hypertension, individualize ventilation/CPP, use evidence-based short antiseizure prophylaxis when chosen, and escalate surgery when indicated.
2023 AAN/AAP/CNS/SCCM consensus guideline: prerequisites, brainstem reflex examination, apnea testing on and off ECMO, valid ancillary tests, plus separate post-declaration donor-management principles.
Recognition and time-sensitive escalation of care for prolonged or repeated seizures.
Analgesia-first sedation, light sedation targets, ABCDEF bundle, spontaneous breathing trials, and non-pharmacologic delirium mitigation.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.